
|Videos|July 27, 2021
Dr. Helfand on the increasing role of genomic testing in prostate cancer
Author(s)Urology Times staff
Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, explains the increased significance of genomic testing in the field of prostate cancer.
Advertisement
Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, explains the increased significance of genomic testing in the field of prostate cancer.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants fast track designation to Enolen for localized prostate cancer
2
Pivotal trial of Butterfly Device for BPH reaches final completion
3
Trial to assess testosterone undecanoate in older men with hypogonadism
4
Genomic classifier score linked with focal therapy outcomes in prostate cancer
5




















